Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Shattuck Labs, Inc. (STTK)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 41,740,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Shattuck Labs is a clinical-stage biopharmaceutical company engaged in developing dual-sided fusion proteins, including its Agonist Redirected Checkpoint and GADLEN™ platforms, as classes of biologic medicines capable of multifunctional activity with applications in oncology and inflammatory diseases. Co.'s product candidate SL-172154, which is in Phase 1 clinical trial for the treatment of patients with ovarian cancer. Co.'s second product candidate, SL-279252, which is developed to inhibit the PD-1/PD-L1 interaction and activate the OX40 costimulatory receptor and is in Phase 1 clinical trial in patients with solid tumors and lymphoma. Co. has several compounds in preclinical development.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 172,871 192,687
Total Buy Value $0 $0 $222,634 $293,713
Total People Bought 0 0 3 3
Total Buy Transactions 0 0 3 5
Total Shares Sold 0 0 133,371 174,375
Total Sell Value $0 $0 $166,714 $585,236
Total People Sold 0 0 1 3
Total Sell Transactions 0 0 1 3
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 149
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Deyoung Casi Chief Business Officer   •       –      –    2025-01-25 4 D $1.16 $2,665 D/D (2,297) 81,465     -
   Shukla Abhinav A. Chief Technical Officer   •       –      –    2025-01-25 4 D $1.16 $2,623 D/D (2,261) 73,536     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2025-01-25 4 D $1.16 $3,725 D/D (3,211) 206,265     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2025-01-10 4 D $1.19 $8,192 D/D (6,884) 209,476     -
   Shukla Abhinav A. Chief Technical Officer   •       –      –    2025-01-10 4 D $1.19 $5,748 D/D (4,830) 74,597     -
   Deyoung Casi Chief Business Officer   •       –      –    2025-01-10 4 D $1.19 $6,815 D/D (5,727) 83,762     -
   Green Jeremy Director   –       •       •   2024-12-04 4 A $1.25 $1,283,610 I/I 1,026,888 5,539,724     -
   Green Jeremy Director   –       •       •   2024-12-04 4 D $1.25 $1,283,610 I/I (1,026,888) 4,512,836     -
   Green Jeremy Director   –       •       •   2024-12-04 4 B $1.25 $166,714 I/I 133,371 5,539,724 2.25     -
   Green Jeremy Director   –       •       •   2024-12-04 4 S $1.25 $166,714 I/I (133,371) 5,406,353     -
   Schreiber Taylor Chief Executive Officer   •       •      –    2024-10-07 4 B $1.21 $44,220 D/D 36,500 71,002 0.01     -
   Brous Tyler   –       •      –    2024-06-28 4 B $3.90 $11,700 D/D 3,000 238,088 0.01     -
   Brous Tyler   –       •      –    2024-06-27 4 B $3.89 $21,068 D/D 5,416 235,088 0.01     -
   Schreiber Taylor Chief Executive Officer   •       •      –    2024-06-26 4 B $3.47 $50,011 D/D 14,400 34,502 0.01     -
   Schreiber Taylor Chief Executive Officer   •       •      –    2024-06-04 4 OE $3.57 $10,889 D/D 3,050 20,102     -
   Stout Stephen See Remarks   •       –      –    2024-05-10 4 D $10.42 $10,076 D/D (967) 73,470     -
   Green Jeremy Director   –       •       •   2024-03-28 4 D $0.00 $0 I/I (4,425) 5,615,489     -
   Stout Stephen See Remarks   •       –      –    2024-03-06 4 AS $10.53 $168,522 D/D (16,004) 74,437     -
   Stout Stephen See Remarks   •       –      –    2024-03-06 4 OE $3.51 $39,380 D/D 11,109 85,791     -
   Shukla Abhinav A. Chief Technical Officer   •       –      –    2024-01-30 4 D $9.99 $22,877 D/D (2,290) 79,427     -
   Stout Stephen See Remarks   •       –      –    2024-01-30 4 D $9.99 $5,924 D/D (593) 79,332     -
   Deyoung Casi Chief Business Officer   •       –      –    2024-01-30 4 D $9.99 $20,060 D/D (2,008) 89,489     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2024-01-30 4 D $9.99 $29,171 D/D (2,920) 216,360     -
   Shukla Abhinav A. Chief Technical Officer   •       –      –    2024-01-10 4 A $0.00 $0 D/D 33,425 81,717     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2024-01-10 4 D $10.09 $30,139 D/D (2,987) 219,280     -
  149 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us